Trial intelligence / Profile preview

Postnatal enalapril for cardiovascular function after preterm pre-eclampsia

NCT03466333Phase 2Completed

Sponsor
Manchester University NHS Foundation Trust
Start
Sep 2018
Primary completion
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of enalapril in cardiovascular disease (CVD), sponsored by Manchester University NHS Foundation Trust. Started Sep 2018; status: completed.

02

Drugs

enalapril
03

Conditions

cardiovascular disease (CVD)

Beyond the preview

Go deeper on NCT03466333.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03466333.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call